Cargando…
Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix
The 3Rs guidelines recommend replacing animal testing with alternative models. One of the solutions proposed is organ-on-chip technology in which liver-on-chip is one of the most promising alternatives for drug screening and toxicological assays. The main challenge is to achieve the relevant in vivo...
Autores principales: | Messelmani, Taha, Le Goff, Anne, Souguir, Zied, Maes, Victoria, Roudaut, Méryl, Vandenhaute, Elodie, Maubon, Nathalie, Legallais, Cécile, Leclerc, Eric, Jellali, Rachid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495334/ https://www.ncbi.nlm.nih.gov/pubmed/36134989 http://dx.doi.org/10.3390/bioengineering9090443 |
Ejemplares similares
-
Validation of HepG2/C3A Cell Cultures in Cyclic Olefin Copolymer Based Microfluidic Bioreactors
por: Etxeberria, Leire, et al.
Publicado: (2022) -
Investigation of the Exometabolomic Profiles of Rat Islets of Langerhans Cultured in Microfluidic Biochip
por: Essaouiba, Amal, et al.
Publicado: (2022) -
Integrated Proteomic and Transcriptomic Investigation of the Acetaminophen Toxicity in Liver Microfluidic Biochip
por: Prot, Jean Matthieu, et al.
Publicado: (2011) -
Miniaturization and Automation of a Human In Vitro Blood–Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery
por: Moya, Elisa L. J., et al.
Publicado: (2021) -
Metastasis-on-a-chip mimicking the progression of kidney cancer in the liver for predicting treatment efficacy
por: Wang, Yimin, et al.
Publicado: (2020)